This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.
Dr. Olivier Lantrès, Fieldfisher
This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.